Evaxion Biotech AS (NAS:EVAX)
$ 2.42 -0.08 (-3.2%) Market Cap: 13.50 Mil Enterprise Value: 16.44 Mil PE Ratio: 0 PB Ratio: 242.00 GF Score: 19/100

Q1 2022 Evaxion Biotech A/S Earnings Call Transcript

May 11, 2022 / 12:30PM GMT
Release Date Price: $19.1 (-15.11%)
Operator

Greetings, and welcome to Evaxion Biotech First Quarter 2022 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Corey Davis of LifeSci Advisors. Please go ahead, sir.

Corey George Davis
LifeSci Advisors, LLC - Relationship Manager

Thanks, Peter. Hello, everyone, and thanks for joining us. I'd like to remind everyone that the following discussion contains certain statements that are considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995.

Because forward-looking statements involve risks and uncertainties, they are not guarantees of future performance, and actual results may differ materially from those expressed or implied by these forward-looking statements due to a variety of factors, including those risk factors discussed in the company's prospectus filed on November 5, 2021, and the company's current and future reports filed with, or submitted to the Securities and Exchange Commission.

At this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot